Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
McKinsey
Chinese Patent Office
Queensland Health
Cantor Fitzgerald
Boehringer Ingelheim

Generated: May 26, 2019

DrugPatentWatch Database Preview

Details for Patent: 5,942,519

« Back to Dashboard

Summary for Patent: 5,942,519
Title: Prevention of precipitated acute urinary retention
Abstract:This invention is concerned with the prevention of precipitated acute urinary retention in a subject male susceptible thereto by the administration of an inhibitor of 5.alpha.-reductase to the subject. The present invention also provides for a method of reducing the risk of precipitated acute urinary retention by the administration of a 5.alpha.-reductase inhibitor to the subject at risk therefor.
Inventor(s): Waldstreicher; Joanne (Scotch Plains, NJ)
Assignee: Merck & Co., Inc. (Rahway, NJ)
Application Number:09/178,138
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 5,942,519
Prior Art and Litigation SupportOrder Prior Art and Litigation support for Patent 5,942,519
Patent Claim Types:
see list of patent claims
Use;

Drugs Protected by US Patent 5,942,519

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate

Subscribe to access the full database, or try a Free Trial

International Family Members for US Patent 5,942,519

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 1279099 ➤ Sign Up
Australia 731576 ➤ Sign Up
Canada 2308070 ➤ Sign Up
European Patent Office 1032400 ➤ Sign Up
Japan 2001521000 ➤ Sign Up
World Intellectual Property Organization (WIPO) 9921563 ➤ Sign Up
Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
US Army
AstraZeneca
Accenture
Citi
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.